Randomized Clinical Trial to Assess the Effectiveness of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 1 (TNT-1 Study)
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Daclatasvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms TNT-1 Study
- 28 Jul 2017 Status changed from active, no longer recruiting to completed.
- 17 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 17 Feb 2017 Planned End Date changed from 1 Mar 2017 to 1 May 2017.